GGS
LLY icon

Galvin Gaustad & Stein’s Eli Lilly LLY Stock Holding History

Galvin Gaustad & Stein’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
1,368
+44
+3% +$45K 0.12% 104
2026
Q1 		$1.22M Sell
1,324
-23
-2% -$23.3K 0.1% 116
2025
Q4 		$1.45M Buy
1,347
+151
+13% +$144K 0.11% 103
2025
Q3 		$913K Sell
1,196
-67
-5% -$49.9K 0.07% 115
2025
Q2 		$984K Sell
1,263
-311
-20% -$242K 0.08% 102
2025
Q1 		$1.3M Sell
1,574
-194
-11% -$161K 0.12% 88
2024
Q4 		$1.36M Sell
1,768
-53
-3% -$43.9K 0.12% 86
2024
Q3 		$1.61M Sell
1,821
-133
-7% -$120K 0.14% 79
2024
Q2 		$1.77M Sell
1,954
-73
-4% -$58.4K 0.16% 72
2024
Q1 		$1.58M Sell
2,027
-483
-19% -$344K 0.15% 77
2023
Q4 		$1.46M Sell
2,510
-105
-4% -$61.3K 0.14% 77
2023
Q3 		$1.4M Sell
2,615
-72
-3% -$37.1K 0.14% 78
2023
Q2 		$1.26M Sell
2,687
-74
-3% -$31K 0.12% 81
2023
Q1 		$948K Sell
2,761
-936
-25% -$316K 0.09% 88
2022
Q4 		$1.35M Sell
3,697
-882
-19% -$313K 0.14% 79
2022
Q3 		$1.48M Sell
4,579
-97
-2% -$30.7K 0.16% 84
2022
Q2 		$1.52M Sell
4,676
-746
-14% -$224K 0.15% 84
2022
Q1 		$1.55M Sell
5,422
-464
-8% -$119K 0.14% 88
2021
Q4 		$1.63M Buy
5,886
+89
+2% +$22.6K 0.14% 92
2021
Q3 		$1.34M Sell
5,797
-1,628
-22% -$402K 0.13% 93
2021
Q2 		$1.7M Sell
7,425
-381
-5% -$76.5K 0.16% 89
2021
Q1 		$1.46M Sell
7,806
-524
-6% -$102K 0.15% 95
2020
Q4 		$1.41M Buy
+8,330
New +$1.24M 0.15% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Galvin Gaustad & Stein's LLY Position: Q2 2026 in Review

Galvin Gaustad & Stein increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $45K and bringing the position to 1,368 shares worth $1.64M. The position accounts for 0.12% of the portfolio, ranked #104.

Galvin Gaustad & Stein first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.77M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Galvin Gaustad & Stein held 1,368 shares of Eli Lilly worth $1.64M as of Q2 2026.
  • Galvin Gaustad & Stein bought 44 Eli Lilly shares in Q2 2026, an estimated $45K.
  • Eli Lilly made up 0.12% of Galvin Gaustad & Stein's portfolio in Q2 2026, its #104 holding.
  • Galvin Gaustad & Stein first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • Galvin Gaustad & Stein's Eli Lilly position peaked at $1.77M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q2 2026, filed 29 Jul 2026.